CAS No.
[129453-61-8 (Unlabeled)]
Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-16,16,17-d3-3,17-diol
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Fulvestrant-d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Fulvestrant-d3 usage and description
Fulvestrant D3 is a medication used for the treatment of breast cancer that has progressed after treatment with other anti-estrogen drugs. It is classified as an estrogen receptor antagonist and is administered via injection into the muscle. Fulvestrant D3 works by binding to the estrogen receptor and blocking the effects of estrogen, which is a hormone that can stimulate the growth of breast cancer cells.
Chemically, Fulvestrant D3 is a synthetic derivative of estradiol, which is a type of estrogen. It is labeled as D3 because it contains three deuterium atoms, which are isotopes of hydrogen. This labeling is used for pharmacokinetic studies to track the distribution, metabolism, and elimination of the drug in the body.
The recommended dosage of Fulvestrant D3 is 500 mg injected into the muscle on days 1, 15, and 29, and then once a month thereafter. It is important to note that the injection should be administered by a healthcare professional in a clinical setting.
Like any medication, Fulvestrant D3 may cause side effects, including nausea, vomiting, hot flashes, headache, fatigue, and injection site reactions. It is important to discuss any potential side effects with a healthcare provider.
In conclusion, Fulvestrant D3 is a medication used for the treatment of advanced breast cancer that works by blocking the effects of estrogen. It is administered via injection and contains three deuterium atoms that are used for pharmacokinetic studies. As with any medication, it is important to discuss potential side effects and dosage with a healthcare provider.
